1. Home
  2. Live Updates
  3. Des tages

Page 2 - Des Tages News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Des tages. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Des Tages Today - Breaking & Trending Today

GNW-Adhoc: Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference call ()

GNW-Adhoc: Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference call ()
aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.

Andrewc Weiss , Corporate Communications , Full Year , Investor Relations , Des Tages ,

XFRA : 90S0: Aussetzung/Suspension ()

XFRA : 90S0: Aussetzung/Suspension () | aktiencheck.de ....

Des Tages , S Rechner , S Vergleich ,

GNW-Adhoc: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond ()

GNW-Adhoc: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond () | aktiencheck.de ....

Switzerland General , United States , Martine Clozel , Andrewc Weiss , Idorsia Ltd , Head Of Investor Relations Corporate Communications , Idorsia Pharmaceuticals Ltd , Swiss Exchange , Chief Financial Officer , Dealer Manager , North America , Vice President , Investor Relations , Pharmaceuticals Ltd , Des Tages ,

Original-Research: Marley Spoon Group SE (von NuWays AG): BUY ()

Original-Research: Marley Spoon Group SE (von NuWays AG): BUY () | aktiencheck.de ....

Marley Spoon Group , Company Name , Equity Research , Mark Sch , Last Friday , Marley Spoon , Spoon Group , Des Tages , S Rechner , S Vergleich ,

GNW-Adhoc: Idorsia and Viatris enter into a significant global research and development collaboration ()

GNW-Adhoc: Idorsia and Viatris enter into a significant global research and development collaboration () | aktiencheck.de ....

South Korea , Andhra Pradesh , United States , Switzerland General , Scotta Smith , Jean Paul Clozel , Andrewc Weiss , Swiss Exchange , Idorsia Pharmaceuticals Ltd , Head Of Investor Relations Corporate Communications , Idorsia Ltd , Viatris Inc , Combines Viatri , First Refusal , Paul Clozel , Chief Executive Officer , Chief Financial Officer , Outcome Study , Acute Myocardial Infarction , Special Protocol Assessment , North America , Vice President , Investor Relations , Pharmaceuticals Ltd , Des Tages , S Rechner ,